Treatment with montelukast in children with asthma. Test trial
Pérez, O.
Revista Alergia Mexico 47(1): 30-32
2000
ISSN/ISBN: 0002-5151 PMID: 10825791 Document Number: 7983
To study of antileukotrienes with participation in the genesis of the asthma appeared in the last years. 17 children with a mean age of 10.29 years, male seven and ten girls. They were tried with montelukast 5 mg/day the 12-year-old smellers and with 10 mg/day the such age greats, during a period middle to 5.7 months. Ten of they had a concomitant treatment fluticasona, budesonide, salmeterol or formoterol. Was valued the clinic improvement, the saving in medication and the sound effects. a) Clinic improvement in 82.3%; b) elimination of medication associated in 90% and c) sound effects: in a case drowsiness and in other abdominal pain. Montelukast seems be a very useful product in the treatment of the bronchial asthma in children since generates a saving of corticoids and longtime beta 2 in the mild or moderate asthma, associate or not with the inmunoterapia.
Document emailed within 1 workday
